<DOC>
	<DOCNO>NCT00033111</DOCNO>
	<brief_summary>The purpose study assess cabergoline Treatment Cocaine Dependence</brief_summary>
	<brief_title>A Study Cabergoline Treatment Cocaine Dependence - 1</brief_title>
	<detailed_description>To assess efficacy safety cabergoline reduce cocaine use subject cocaine dependence . This DB , placebo-controlled , parallel group design study subject receive either .5mg cabergoline placebo 12 week 4 week follow-up .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Must DSM4 criterion cocaine dependence ; seek treatment cocaine dependence ; ability understand provide write informed consent ; female childbearing potential use proper method birth control . Additional criterion available screen site .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>